| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein
|
Wang, Guan
|
|
2011
|
69 |
3 |
p. 799-805
|
artikel
|
| 2 |
Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy
|
Brandts, Christian H.
|
|
2011
|
69 |
3 |
p. 613-620
|
artikel
|
| 3 |
An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function
|
O’Bryant, Cindy L.
|
|
2011
|
69 |
3 |
p. 605-612
|
artikel
|
| 4 |
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study
|
Chao, Joseph
|
|
2011
|
69 |
3 |
p. 835-843
|
artikel
|
| 5 |
A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer
|
Chow, L. Q. M.
|
|
2011
|
69 |
3 |
p. 709-722
|
artikel
|
| 6 |
A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
|
Rodon, Jordi
|
|
2011
|
69 |
3 |
p. 825-834
|
artikel
|
| 7 |
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
|
Wakelee, Heather A.
|
|
2011
|
69 |
3 |
p. 815-824
|
artikel
|
| 8 |
A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
|
Fury, Matthew G.
|
|
2011
|
69 |
3 |
p. 591-598
|
artikel
|
| 9 |
A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
|
Fakih, M. G.
|
|
2011
|
69 |
3 |
p. 743-751
|
artikel
|
| 10 |
Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells
|
King, C. L.
|
|
2011
|
69 |
3 |
p. 665-677
|
artikel
|
| 11 |
Effect of food and a proton pump inhibitor on the pharmacokinetics of S-1 following oral administration of S-1 in patients with advanced solid tumors
|
Scheulen, Max E.
|
|
2011
|
69 |
3 |
p. 753-761
|
artikel
|
| 12 |
Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice
|
Zhongfa, Liu
|
|
2011
|
69 |
3 |
p. 679-689
|
artikel
|
| 13 |
Evaluation of a formula for individual dosage of nedaplatin based on renal function
|
Sato, Shinya
|
|
2011
|
69 |
3 |
p. 599-603
|
artikel
|
| 14 |
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX
|
Mazard, T.
|
|
2011
|
69 |
3 |
p. 807-814
|
artikel
|
| 15 |
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer
|
Chung, Vincent
|
|
2011
|
69 |
3 |
p. 733-741
|
artikel
|
| 16 |
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis
|
Lombardi, Giuseppe
|
|
2011
|
69 |
3 |
p. 781-787
|
artikel
|
| 17 |
In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues
|
Haglund, Caroline
|
|
2011
|
69 |
3 |
p. 697-707
|
artikel
|
| 18 |
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
|
Zhu, Wei
|
|
2011
|
69 |
3 |
p. 723-731
|
artikel
|
| 19 |
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice
|
Hurwitz, Selwyn J.
|
|
2011
|
69 |
3 |
p. 577-590
|
artikel
|
| 20 |
Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
|
Chen, Nianhang
|
|
2011
|
69 |
3 |
p. 789-797
|
artikel
|
| 21 |
Pharmacokinetics of carboplatin in a hemodialysis patient with small-cell lung cancer
|
Hiraike, Mikako
|
|
2011
|
69 |
3 |
p. 845-848
|
artikel
|
| 22 |
Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys
|
Jung, Donald
|
|
2011
|
69 |
3 |
p. 643-654
|
artikel
|
| 23 |
Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data
|
Koo, Dong Hoe
|
|
2011
|
69 |
3 |
p. 655-663
|
artikel
|
| 24 |
Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma
|
Lee, Eun Mi
|
|
2011
|
69 |
3 |
p. 635-642
|
artikel
|
| 25 |
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
|
Petrini, Iacopo
|
|
2011
|
69 |
3 |
p. 773-780
|
artikel
|
| 26 |
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
|
Petrini, Iacopo
|
|
|
69 |
3 |
p. 773-780
|
artikel
|
| 27 |
Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial
|
Antonarakis, Emmanuel S.
|
|
2011
|
69 |
3 |
p. 763-771
|
artikel
|
| 28 |
Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells
|
Chu, Pei-Ming
|
|
2011
|
69 |
3 |
p. 621-633
|
artikel
|
| 29 |
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue
|
Chiusolo, Patrizia
|
|
2011
|
69 |
3 |
p. 691-696
|
artikel
|
Tijdschrift beschrijving